Intravenous Artesunate for Severe Malaria in Travelers, Europe

Multicenter trials in Southeast Asia have shown better survival rates among patients with severe malaria, particularly those with high parasitemia levels, treated with intravenous (IV) artesunate than among those treated with quinine. In Europe, quinine is still the primary treatment for severe mala...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Zoller, Thomas, Junghanss, Thomas, Kapaun, Annette, Gjørup, Ida, Richter, Joachim, Hugo-Persson, Mats, Mørch, Kristine, Foroutan, Behruz, Suttorp, Norbert, Yürek, Salih, Flick, Holger
Format: Artigo
Idioma:Inglês
Publicat: Centers for Disease Control and Prevention 2011
Matèries:
Synopsis
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3321768/
https://ncbi.nlm.nih.gov/pubmed/21529383
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid1705.101229
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars